|
1
|
Ikee R, Honda K, Ishioka K, Oka M, Maesato
K, Moriya H, Hidaka S, Ohtake T and Kobayashi S: Differences in
associated factors between aortic and mitral valve calcification in
hemodialysis. Hypertens Res. 33:622–626. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guerraty MA, Chai B, Hsu JY, Ojo AO, Gao
Y, Yang W, Keane MG, Budoff MJ and Mohler ER III; CRIC Study
Investigators, : Relation of aortic valve calcium to chronic kidney
disease (from the Chronic Renal Insufficiency Cohort Study). Am J
Cardiol. 115:1281–1286. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barreto FC, Barreto DV, Liabeuf S, Meert
N, Glorieux G, Temmar M, Choukroun G, Vanholder R and Massy ZA;
European Uremic Toxin Work Group (EUTox), : Serum indoxyl sulfate
is associated with vascular disease and mortality in chronic kidney
disease patients. Clin J Am Soc Nephrol. 4:1551–1558. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chiu CA, Lu LF, Yu TH, Hung WC, Chung FM,
Tsai IT, Yang CY, Hsu CC, Lu YC, Wang CP and Lee YJ: Increased
levels of total P-Cresylsulphate and indoxyl sulphate are
associated with coronary artery disease in patients with diabetic
nephropathy. Rev Diabet Stud. 7:275–284. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liabeuf S, Barreto DV, Barreto FC, Meert
N, Glorieux G, Schepers E, Temmar M, Choukroun G, Vanholder R and
Massy ZA; European Uraemic Toxin Work Group (EUTox), : Free
p-cresylsulphate is a predictor of mortality in patients at
different stages of chronic kidney disease. Nephrol Dial
Transplant. 2010.25:1183–1191. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Viaene L, Meijers BK, Bammens B,
Vanrenterghem Y and Evenepoel P: Serum concentrations of p-cresyl
sulfate and indoxyl sulfate, but not inflammatory markers, increase
in incident peritoneal dialysis patients in parallel with loss of
residual renal function. Perit Dial Int. 34:71–78. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Su H, Gao D, Chen Y and Zuo Z: The
relationship between klotho and SIRT1 expression in renal aging
related disease. Int J Gen Med. 15:7885–7893. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hu MC, Kuro-o M and Moe OW: Klotho and
chronic kidney disease. Contrib Nephrol. 180:47–63. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Giachelli CM: The emerging role of
phosphate in vascular calcification. Kidney Int. 75:890–897. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lindberg K, Amin R, Moe OW, Hu MC, Erben
RG, Ostman Wernerson A, Lanske B, Olauson H and Larsson TE: The
kidney is the principal organ mediating klotho effects. J Am Soc
Nephrol. 25:2169–2175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu MC, Shi M, Zhang J, Quinones H,
Griffith C, Kuro-o M and Moe OW: Klotho deficiency causes vascular
calcification in chronic kidney disease. J Am Soc Nephrol.
22:124–136. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yan J, Wang J, He JC and Zhong Y: Sirtuin
1 in chronic kidney disease and therapeutic potential of targeting
Sirtuin 1. Front Endocrinol (Lausanne). 13:9177732022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun CY, Chang SC and Wu MS: Suppression of
Klotho expression by protein-bound uremic toxins is associated with
increased DNA methyltransferase expression and DNA
hypermethylation. Kidney Int. 81:640–650. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu H, Li Y and Xiong J: The role of
hypoxia-inducible factor-1 alpha in renal disease. Molecules.
27:73182022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Marxsen JH, Stengel P, Doege K, Heikkinen
P, Jokilehto T, Wagner T, Jelkmann W, Jaakkola P and Metzen E:
Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by
induction of HIF-alpha-prolyl-4-hydroxylases. Biochem J. 381((Pt
3)): 761–767. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu TK, Wei CW, Pan YR, Hsu RJ, Wu CY and
Yu YL: The uremic toxin p-cresyl sulfate induces proliferation and
migration of clear cell renal cell carcinoma via microRNA-21/HIF-1α
axis signals. Sci Rep. 9:32072019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie L, Wang Y, Li Q, Ji X, Tu Y, Du S, Lou
H, Zeng X, Zhu L, Zhang J and Zhu M: The
HIF-1α/p53/miRNA-34a/Klotho axis in retinal pigment epithelial
cells promotes subretinal fibrosis and exacerbates choroidal
neovascularization. J Cell Mol Med. 25:1700–1711. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen J, Lin Y and Sun Z: Deficiency in the
anti-aging gene Klotho promotes aortic valve fibrosis through
AMPKalpha-mediated activation of RUNX2. Aging Cell. 15:853–860.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li F, Yao Q, Ao L, Cleveland JC Jr, Dong
N, Fullerton DA and Meng X: Klotho suppresses high
phosphate-induced osteogenic responses in human aortic valve
interstitial cells through inhibition of Sox9. J Mol Med (Berl).
95:739–751. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li SJ, Kao YH, Chung CC, Chen WY, Cheng WL
and Chen YJ: Activated p300 acetyltransferase activity modulates
aortic valvular calcification with osteogenic transdifferentiation
and downregulation of Klotho. Int J Cardiol. 232:271–279. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao D, Zuo Z, Tian J, Ali Q, Lin Y, Lei H
and Sun Z: Activation of SIRT1 attenuates klotho deficiency-induced
arterial stiffness and hypertension by enhancing AMP-activated
protein kinase activity. Hypertension. 68:1191–1199. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Carter S, Miard S, Roy-Bellavance C,
Boivin L, Li Z, Pibarot P, Mathieu P and Picard F: Sirt1 inhibits
resistin expression in aortic stenosis. PLoS One. 7:e351102012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cai Z, Wang J, Liu M, Yuan T and Li F:
Abstract 12300: Sirtuin 1 Prevents Age-associated Aortic Valve
Calcification in vivo. Circulation. 140 (Suppl 1):A123002019.
|
|
24
|
Lu C, Zhao H, Liu Y, Yang Z, Yao H, Liu T,
Gou T, Wang L, Zhang J, Tian Y, et al: Novel Role of the SIRT1 in
endocrine and metabolic diseases. Int J Biol Sci. 19:484–501. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu TF and McCall CE: Deacetylation by
SIRT1 reprograms inflammation and cancer. Genes Cancer. 4:135–147.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bartoli-Leonard F, Wilkinson FL, Schiro A,
Inglott FS, Alexander MY and Weston R: Suppression of SIRT1 in
diabetic conditions induces osteogenic differentiation of human
vascular smooth muscle cells via RUNX2 signalling. Sci Rep.
9:8782019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Poesen R, Viaene L, Verbeke K, Augustijns
P, Bammens B, Claes K, Kuypers D, Evenepoel P and Meijers B:
Cardiovascular disease relates to intestinal uptake of p-cresol in
patients with chronic kidney disease. BMC Nephrol. 15:872014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fu Q, Colgan SP and Shelley CS: Hypoxia:
The force that drives chronic kidney disease. Clin Med Res.
14:15–39. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hirakawa Y, Tanaka T and Nangaku M: Renal
hypoxia in CKD; Pathophysiology and detecting methods. Front
Physiol. 8:992017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu M, Ning X, Li R, Yang Z, Yang X, Sun S
and Qian Q: Signalling pathways involved in hypoxia-induced renal
fibrosis. J Cell Mol Med. 21:1248–1259. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chern YB, Chia KL, Liu CH, Lin YL, Tsai JP
and Hsu BG: Serum p-Cresyl sulfate is independently associated with
aortic stiffness in non-dialysis chronic kidney disease patients.
Life (Basel). 15:11162025.PubMed/NCBI
|
|
32
|
Zoccali C, Mallamaci F, Adamczak M, de
Oliveira RB, Massy ZA, Sarafidis P, Agarwal R, Mark PB, Kotanko P,
Ferro CJ, et al: Cardiovascular complications in chronic kidney
disease: A review from the European renal and cardiovascular
medicine working group of the European renal association.
Cardiovasc Res. 119:2017–2032. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu Q, Liu Z, Guo L, Liu R, Li R, Chu X,
Yang J, Luo J, Chen F and Deng M: Hypoxia mediates runt-related
transcription factor 2 expression via induction of vascular
endothelial growth factor in periodontal ligament stem cells. Mol
Cells. 42:763–772. 2019.PubMed/NCBI
|
|
34
|
Li SJ, Kao YH, Chung CC, Cheng WL, Lin YK
and Chen YJ: Vascular endothelial growth factor on Runt-related
transcript factor-2 in aortic valve cells. Eur J Clin Invest.
51:e134702021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gryp T, Vanholder R, Vaneechoutte M and
Glorieux G: p-Cresyl Sulfate. Toxins (Basel). 9:522017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Watanabe H, Miyamoto Y, Enoki Y, Ishima Y,
Kadowaki D, Kotani S, Nakajima M, Tanaka M, Matsushita K, Mori Y,
et al: p-Cresyl sulfate, a uremic toxin, causes vascular
endothelial and smooth muscle cell damages by inducing oxidative
stress. Pharmacol Res Perspect. 3:e000922015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Afsar B, Kanbay M and Afsar RE:
Interconnections of fibroblast growth factor 23 and klotho with
erythropoietin and hypoxia-inducible factor. Mol Cell Biochem.
477:1973–1985. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
He T, Xiong J, Huang Y, Zheng C, Liu Y, Bi
X, Liu C, Han W, Yang K, Xiao T, et al: Klotho restrain RIG-1/NF-ĸB
signaling activation and monocyte inflammatory factor release under
uremic condition. Life Sci. 231:1165702019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu T, Zhang L, Joo D and Sun SC: NF-ĸB
signaling in inflammation. Signal Transduct Target Ther.
2:17023–2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhao Y, Banerjee S, Dey N, LeJeune WS,
Sarkar PS, Brobey R, Rosenblatt KP, Tilton RG and Choudhary S:
Klotho depletion contributes to increased inflammation in kidney of
the db/db mouse model of diabetes via RelA (serine)536
phosphorylation. Diabetes. 60:1907–1916. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Han W, Wang C, Yang Z, Mu L, Wu M, Chen N,
Du C, Duan H and Shi Y: SRT1720 retards renal fibrosis via
inhibition of HIF1A/GLUT1 in diabetic nephropathy. J Endocrinol.
241:85–98. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Szymanska M, Manthe S, Shrestha K, Girsh
E, Harlev A, Kisliouk T and Meidan R: Sirtuin-1 inhibits
endothelin-2 expression in human granulosa-lutein cells via hypoxia
inducible factor 1 alpha and epigenetic modifications †. Biol
Reprod. 104:387–398. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ryu DR, Yu MR, Kong KH, Kim H, Kwon SH,
Jeon JS, Han DC and Noh H: Sirt1-hypoxia-inducible factor-1α
interaction is a key mediator of tubulointerstitial damage in the
aged kidney. Aging Cell. 18:e129042019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Abraham CR, Chen C, Cuny GD, Glicksman MA
and Zeldich E: Small-molecule Klotho enhancers as novel treatment
of neurodegeneration. Future Med Chem. 4:1671–1679. 2012.
View Article : Google Scholar : PubMed/NCBI
|
